XARELTO®: Chronic coronary artery disease and peripheral artery disease treatment

XARELTO® 2.5 mg VASCULAR DOSE:Significantly reduced a composite of cv death, mi, and stroke‡ in combination with aspirin in patients with chronic CAD or PAD2

*Patients with chronic coronary syndromes (chronic CAD) and in sinus rhythm.

XARELTO® 2.5 mg twice daily with aspirin 100 mg once daily.

Major cardiovascular events were a composite of cardiovascular death, myocardial infarction, or stroke.

CAD = coronary artery disease; CV = cardiovascular; DOAC = direct oral anticoagulant; ESC = European Society of Cardiology; MI = myocardial infarction; PAD = peripheral artery disease.